tiprankstipranks
Trending News
More News >
Ecolab Inc (ECL)
NYSE:ECL

Ecolab (ECL) AI Stock Analysis

Compare
1,377 Followers

Top Page

EC

Ecolab

(NYSE:ECL)

77Outperform
Ecolab exhibits strong financial performance with consistent revenue growth and profitability, supported by effective cost management and strategic investments. Technical analysis suggests positive momentum, though caution is advised due to potential overbought conditions. Valuation remains high, reflecting growth expectations. The earnings call and recent board appointment add positive sentiment, although challenges in the global trade environment present risks. Overall, Ecolab demonstrates a robust position in its industry with promising growth potential.
Positive Factors
Earnings Performance
First-quarter results showed an adjusted EPS increase of 12%, aligning with consensus estimates.
Growth Strategy
ECL's proactive pricing strategies and increased value proposition are expected to contribute to consistent double-digit EPS growth in future years.
Market Position
ECL is viewed as a best-in-class 'safe haven' stock, which is expected to push the stock higher as it demonstrates resilience.
Negative Factors
Organic Growth Concerns
There is investor concern about softer-than-expected organic growth in the Water segment and a fear that a tariff-related price hike might be reactionary.
Tariff Impact
Tariffs pose risks impacting 10% of its raw materials from other geographies.

Ecolab (ECL) vs. S&P 500 (SPY)

Ecolab Business Overview & Revenue Model

Company DescriptionEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
How the Company Makes MoneyEcolab makes money through a diverse revenue model that includes the sale of products, services, and consultation. Its key revenue streams originate from its three main segments: Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences. The Global Industrial segment provides water treatment and process applications, cleaning and sanitizing solutions, and services to industries such as food and beverage, manufacturing, and chemicals. The Global Institutional & Specialty segment focuses on serving customers in hospitality, food service, healthcare, and retail with cleaning and sanitizing products and services. The Global Healthcare & Life Sciences segment offers infection prevention and surgical solutions. Ecolab's earnings are significantly enhanced by its customer partnerships, which involve service contracts and long-term agreements, ensuring recurring revenue. Additionally, the company's focus on innovation and sustainability attracts environmentally conscious clients, further driving its business growth.

Ecolab Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down sales figures by business unit, offering insight into which areas are generating the most revenue and indicating potential growth drivers or areas needing attention.
Chart InsightsEcolab's Industrial segment is experiencing robust growth, with a notable increase in revenue over recent quarters, reflecting strong demand and effective pricing strategies. The Institutional and Specialty segment also shows steady growth, aligning with Ecolab's focus on expanding high-growth sectors like data centers and microelectronics. However, the Healthcare and Lifesciences segment is facing challenges, with a recent decline in revenue. The earnings call highlights a promising outlook for 2025, with strategic initiatives expected to drive earnings growth despite currency translation impacts and volume growth challenges.
Data provided by:Main Street Data

Ecolab Financial Statement Overview

Summary
Ecolab showcases a strong financial performance, driven by consistent revenue growth and robust profitability margins. The balance sheet reflects a stable capital structure with manageable leverage, while the cash flow position underscores efficient cash generation capabilities. Despite some fluctuations in free cash flow, the overall outlook remains positive, supported by strategic investments and effective cost management.
Income Statement
85
Very Positive
Ecolab's income statement reflects strong profitability with a consistent increase in gross profit margin from 41.4% in 2020 to 43.7% in TTM 2025. The net profit margin has also improved, reaching 13.4% in TTM 2025, indicating efficient cost management. Revenue growth has been steady, with a notable 21.0% increase from 2020 to 2021 and continued growth across subsequent years, though slightly declining in TTM 2025. EBIT and EBITDA margins have shown robust performance, reflecting operational efficiency. Overall, Ecolab demonstrates solid revenue growth and profitability metrics.
Balance Sheet
78
Positive
Ecolab's balance sheet shows a stable financial position with a debt-to-equity ratio of 0.93 in TTM 2025, highlighting moderate leverage. The return on equity has improved from 15.9% in 2020 to 23.7% in TTM 2025, indicating effective use of shareholder equity. The equity ratio remains reasonable at 39.7%, suggesting a balanced capital structure. However, the company's total debt level, while stable, remains significant, which could pose a risk in adverse economic conditions.
Cash Flow
82
Very Positive
Ecolab's cash flow statement reveals a healthy free cash flow generation, with a growth rate of 27.5% from 2022 to TTM 2025. The operating cash flow to net income ratio is strong at 1.03 in TTM 2025, indicating solid cash generation relative to net income. However, the decline in free cash flow from 2024 to TTM 2025 suggests potential volatility in cash flow despite overall positive performance. The company maintains a focus on capital investments, supporting future growth.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
15.74B15.32B14.19B12.73B11.79B
Gross Profit
6.84B6.19B5.36B5.12B4.88B
EBIT
2.80B1.99B788.80M892.00M818.50M
EBITDA
3.85B3.03B2.79B2.71B2.50B
Net Income Common Stockholders
2.11B1.37B1.09B1.13B984.80M
Balance SheetCash, Cash Equivalents and Short-Term Investments
1.26B919.50M598.60M359.90M1.26B
Total Assets
22.39B21.85B21.46B21.21B18.13B
Total Debt
8.28B8.73B8.92B9.04B6.99B
Net Debt
7.03B7.81B8.32B8.68B5.73B
Total Liabilities
13.60B13.77B14.21B13.95B11.92B
Stockholders Equity
8.76B8.04B7.24B7.22B6.17B
Cash FlowFree Cash Flow
1.82B1.64B1.08B1.42B1.37B
Operating Cash Flow
2.81B2.41B1.79B2.06B1.86B
Investing Cash Flow
-433.80M-990.50M-716.80M-4.58B-414.50M
Financing Cash Flow
-2.02B-1.05B-837.30M1.60B-341.80M

Ecolab Technical Analysis

Technical Analysis Sentiment
Positive
Last Price255.38
Price Trends
50DMA
250.46
Positive
100DMA
247.38
Positive
200DMA
246.90
Positive
Market Momentum
MACD
0.58
Negative
RSI
62.41
Neutral
STOCH
92.68
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ECL, the sentiment is Positive. The current price of 255.38 is above the 20-day moving average (MA) of 239.01, above the 50-day MA of 250.46, and above the 200-day MA of 246.90, indicating a bullish trend. The MACD of 0.58 indicates Negative momentum. The RSI at 62.41 is Neutral, neither overbought nor oversold. The STOCH value of 92.68 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ECL.

Ecolab Risk Analysis

Ecolab disclosed 23 risk factors in its most recent earnings report. Ecolab reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ecolab Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
SHSHW
78
Outperform
$90.13B34.0370.22%0.82%0.26%12.82%
ECECL
77
Outperform
$72.43B34.7424.62%0.95%1.19%36.31%
RPRPM
69
Neutral
$14.17B22.0925.53%1.80%-0.61%15.06%
DDDD
63
Neutral
$28.14B40.243.12%2.30%2.64%80.37%
PPPPG
62
Neutral
$25.08B18.7218.47%2.43%-7.67%-0.58%
APAPD
59
Neutral
$61.78B40.3510.45%2.56%-1.09%-37.71%
49
Neutral
$1.95B-1.27-21.38%3.72%0.83%-29.30%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ECL
Ecolab
255.38
28.66
12.64%
APD
Air Products and Chemicals
277.62
36.15
14.97%
PPG
PPG Industries
110.49
-19.68
-15.12%
RPM
RPM International
110.31
0.97
0.89%
SHW
Sherwin-Williams Company
359.64
47.25
15.13%
DD
DuPont de Nemours
67.25
-9.82
-12.74%

Ecolab Earnings Call Summary

Earnings Call Date:Apr 29, 2025
(Q1-2025)
|
% Change Since: 6.84%|
Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment Neutral
Ecolab showcased strong earnings growth, margin improvement, and success in the Life Sciences and digital segments. However, challenges in the global trade environment, industrial market softness, and increased costs due to tariffs present notable concerns.
Q1-2025 Updates
Positive Updates
Strong Earnings Growth
Ecolab experienced a strong quarter with double-digit earnings growth, including 3% organic sales growth and 12% EPS growth, outpacing the software markets.
Operating Income Margin Improvement
The company achieved a 190 basis point increase in operating income margin, aiming for a 20% operating income margin by 2027.
Life Sciences Segment Success
Life Sciences grew organic sales mid-single-digits with over 30% growth in organic operating income, driven by double-digit growth in the biopharma business.
Robust Free Cash Flow
Ecolab reported strong and resilient free cash flow, with a healthy balance sheet, over $1 billion in cash, and a 1.8x net debt to adjusted EBITDA ratio.
Ecolab Digital Growth
Ecolab Digital sales grew 12% to $80 million in the first quarter, with expectations for acceleration throughout the year, driven by strong growth in subscription revenue.
Negative Updates
Global Trade Environment Concerns
Ecolab faces challenges from a rapidly changing global trade environment, including a 10% global baseline tariff and a 145% tariff on China, impacting costs.
Industrial Market Softness
There is a noted softness in demand, particularly in heavy industrial markets, with expectations for continued softness throughout the year.
Increased Costs Due to Tariffs
The tariffs have resulted in increased costs for raw materials, packaging, and some equipment, with an anticipated impact of a few hundred million dollars annually.
Pest Elimination Challenges
Pest Elimination segment faced safety issues negatively impacting profitability, though improvement is expected in the second quarter.
Company Guidance
In the Ecolab First Quarter 2025 earnings call, the company reported strong financial performance with double-digit earnings growth, attributed to a 3% increase in organic sales and a 12% rise in earnings per share (EPS). Ecolab also achieved a 190 basis point improvement in operating income margin, progressing towards a 20% margin goal by 2027. Despite facing challenges such as a complex global operating environment and increased tariffs, Ecolab announced a 5% trade surcharge for U.S. customers to offset these costs. The company is focused on growth initiatives, including the One Ecolab strategy, which has delivered significant market share gains. Ecolab's investments in digital technologies like Ecolab Digital, which saw sales grow 12% to $80 million in the first quarter, and other growth engines like Life Sciences and Pest Intelligence, are also expected to fuel future sales growth and margin expansion.

Ecolab Corporate Events

Executive/Board Changes
Ecolab Appoints Michel Doukeris to Board of Directors
Positive
Feb 20, 2025

On February 20, 2025, Ecolab Inc. announced the appointment of Michel Doukeris, CEO of AB InBev, to its board of directors. Doukeris is expected to bring significant global executive experience and strategic insights to Ecolab, enhancing its mission to protect vital resources and drive sustainable growth. His appointment follows the decision of Arthur J. Higgins not to seek re-election at the annual meeting in May 2025. Higgins’ departure is amicable, and the board acknowledged his valuable contributions over the years.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.